Camber Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Camber Capital Management’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-136,111	Closed	-$6.29M	–	47
2021 Q4	$6.29M	Sell	136,111 -125,000	-48%	-$7.18M	0.22%	33
2021 Q3	$17.5M	Hold	261,111	–	–	0.54%	38
2021 Q2	$27.9M	Hold	261,111	–	–	0.94%	31
2021 Q1	$39.8M	Hold	261,111	–	–	1.36%	26
2020 Q4	$43.7M	Buy	261,111 +111,111	+74%	+$19.8M	1.53%	20
2020 Q3	$23.4M	Buy	150,000 +37,500	+33%	+$7.56M	1.24%	26
2020 Q2	$23.6M	Hold	112,500	–	–	1.35%	21
2020 Q1	$21M	Buy	112,500 +62,500	+125%	+$14.7M	1.25%	22
2019 Q4	$12.1M	Buy	50,000 +8,333	+20%	+$1.61M	0.61%	28
2019 Q3	$7.06M	Buy	+41,667	New	+$9.43M	0.37%	32

Other funds holding TECX

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Camber Capital Management's TECX Position: Q1 2022 in Review

Camber Capital Management sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 136,111 shares — an estimated $6.29M sold.

Camber Capital Management first reported a position in TECX in Q3 2019 and held it in 10 quarters. The position peaked at $43.7M in Q4 2020. 80 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

Camber Capital Management reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
Camber Capital Management sold 136,111 Tectonic Therapeutic shares in Q1 2022, an estimated $6.29M.
Camber Capital Management first reported a position in Tectonic Therapeutic in Q3 2019 and held it in 10 quarters.
Camber Capital Management's Tectonic Therapeutic position peaked at $43.7M in Q4 2020.
80 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on Camber Capital Management's 13F filing for Q1 2022, filed 16 May 2022.